Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 77 | 3 | 2 | 1 | €275.80 | €332.93 | 20.714% |
| Boston Scientific | 68 | 0 | 8 | 0 | €54.58 | €103.39 | 89.437% |
| Eli Lilly Corp. | 70 | 2 | 5 | 0 | €787.60 | €992.11 | 25.966% |
| Insmed Inc. | 66 | 0 | 11 | 0 | €120.36 | €177.49 | 47.466% |
| Abbott Laboratories | 59 | 0 | 19 | 0 | €82.28 | €118.19 | 43.641% |
| Insulet Corp. | 55 | 0 | 6 | 0 | €173.05 | €315.13 | 82.103% |
| Gilead Sciences Inc | 55 | 0 | 3 | 0 | €116.94 | €124.75 | 6.678% |
| Intuitive Surgical Inc | 56 | 2 | 4 | 0 | €398.70 | €521.79 | 30.873% |
| Neurocrine Bioscience | 52 | 0 | 5 | 0 | €113.20 | €148.60 | 31.269% |
| Ionis Pharmaceuticals Inc. | 50 | 1 | 4 | 0 | €64.34 | €77.41 | 20.312% |
| Vertex Pharmaceuticals Inc. | 47 | 0 | 1 | 0 | €374.90 | €461.98 | 23.227% |
| Alnylam Pharmace. | 46 | 0 | 3 | 0 | €263.10 | €428.30 | 62.789% |
| HCA Holdings Inc. | 45 | 0 | 0 | 0 | €414.70 | €445.59 | 7.448% |
| Regeneron Pharmaceuticals Inc. | 44 | 0 | 3 | 0 | €637.90 | €707.12 | 10.851% |
| Johnson & Johnson | 44 | 1 | 11 | 0 | €198.98 | €215.09 | 8.098% |
| Dexcom Inc. | 43 | 1 | 1 | 0 | €54.40 | €77.13 | 41.783% |
| Cytokinetics Inc. | 42 | 0 | 2 | 0 | €56.68 | €72.11 | 27.230% |
| Rhythm Pharmaceuticals | 41 | 0 | 0 | 0 | €74.00 | €109.86 | 48.455% |
| Cigna Corp. | 37 | 0 | 1 | 0 | €236.80 | €306.38 | 29.382% |
| Medtronic plc | 38 | 1 | 5 | 0 | €73.24 | €95.74 | 30.717% |
| Thermo Fisher Scientific Inc. | 35 | 0 | 2 | 0 | €447.30 | €504.64 | 12.819% |
| Jazz Pharmaceuticals plc | 35 | 0 | 1 | 0 | €172.90 | €176.91 | 2.320% |
| Acadia Pharmaceuticals | 34 | 1 | 1 | 0 | €18.84 | €28.15 | 49.468% |
| Edwards Lifesciences Corp. | 32 | 0 | 2 | 0 | €68.82 | €80.91 | 17.570% |
| Amgen Inc. | 35 | 3 | 2 | 0 | €301.85 | €312.46 | 3.514% |